Hofseth BioCare ASA (OSL:HBC)

Hofseth BioCare ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	33.61	67.05	25.58	23.89	32.43	49.92
Cash & Short-Term Investments	33.61	67.05	25.58	23.89	32.43	49.92
Cash Growth	-48.67%	162.15%	7.06%	-26.33%	-35.04%	-71.12%
Accounts Receivable	43.11	21.52	18.85	14.85	14.07	10.09
Other Receivables	-	5.62	5.9	4.92	6.84	13.37
Receivables	43.11	27.14	24.76	19.76	20.91	23.46
Inventory	58.09	59.83	55.92	82.54	116.53	90.81
Prepaid Expenses	-	5.34	4.59	2.55	1.51	1.61
Other Current Assets	12.83	2.43	1.23	2.26	4.38	4.51
Total Current Assets	147.64	161.79	112.06	131	175.75	170.31
Property, Plant & Equipment	135.3	146.93	137.98	165.7	168.79	185.83
Long-Term Investments	-	47.85	45.7	37.69	5.56	5.76
Other Intangible Assets	31.8	3.2	3.98	5.43	6.46	53.06
Long-Term Deferred Charges	-	33.3	38.45	49.85	54.13	-
Other Long-Term Assets	44.89	1.2	1.25	0.44	0.34	1.01
Total Assets	359.63	394.27	339.42	390.12	411.03	415.97

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	71.83	94.62	93.63	55.16	145.75	124.17
Accrued Expenses	-	15.25	15.56	13.03	13.08	12.25
Short-Term Debt	-	115.69	47.75	172.35	-	-
Current Portion of Long-Term Debt	74.39	-	0.27	0.54	0.54	2.42
Current Portion of Leases	-	15.66	11.22	10.79	12.86	12.1
Other Current Liabilities	8.23	0	0	-	-	-
Total Current Liabilities	154.46	241.22	168.42	251.88	172.23	150.93
Long-Term Debt	207.64	139	25.1	0.27	0.81	23.79
Long-Term Leases	-	89.59	86.54	96.83	89.96	100.88
Other Long-Term Liabilities	-	0	-	-	-	-0
Total Liabilities	362.09	469.81	280.07	348.98	263	275.6

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5.22	4.11	4.11	3.95	3.95	3.58
Additional Paid-In Capital	-	-	55.93	37.88	144.77	137.49
Comprehensive Income & Other	-7	-78.96	-0	-	-	-
Total Common Equity	-1.78	-74.84	60.04	41.83	148.72	141.06
Minority Interest	-0.69	-0.69	-0.69	-0.69	-0.69	-0.69
Shareholders' Equity	-2.47	-75.53	59.36	41.14	148.03	140.38
Total Liabilities & Equity	359.63	394.27	339.42	390.12	411.03	415.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	282.03	359.94	170.88	280.79	104.17	139.18
Net Cash (Debt)	-248.42	-292.89	-145.3	-256.9	-71.74	-89.26
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.56	-0.71	-0.35	-0.65	-0.19	-0.25
Filing Date Shares Outstanding	429.03	411.08	411.08	395.08	395.08	357.83
Total Common Shares Outstanding	429.03	411.08	411.08	395.08	395.08	357.83
Working Capital	-6.82	-79.42	-56.36	-120.87	3.52	19.38
Book Value Per Share	-0.00	-0.18	0.15	0.11	0.38	0.39
Tangible Book Value	-33.58	-78.05	56.06	36.39	142.25	88.01
Tangible Book Value Per Share	-0.08	-0.19	0.14	0.09	0.36	0.25
Machinery	-	234.67	-	212.49	204.3	199.52

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error